Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Weiss

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Digital Health|June 16, 2023
Effectiveness of biofeedback-assisted asynchronous telerehabilitation in musculoskeletal care: A systematic reviewDora Janela, Fabíola Costa, Brandon Weiss, et al.
Psychological Medicine|June 2, 2023
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionBrandon Weiss, Induni Ginige, Lu Shannon, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
Neuroscience and Biobehavioral Reviews|February 4, 2024
Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personalityIvana Solaja, Kate Haldane, Natasha Mason, et al.
Sleep|February 6, 2014
Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trialLisa S Talbot, Shira Maguen, Thomas J Metzler, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Ayahuasca: A review of historical, pharmacological, and therapeutic aspectsSimon G D Ruffell, Max Crosland-Wood, Rob Palmer, et al.
Nature Medicine|February 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trialDavid Erritzoe, Tommaso Barba, Tiffanie Benway, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approachClaudio Agnorelli, Joseph Peill, Gabriela Sawicka, et al.
Harm Reduction Journal|December 31, 2025
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysisMichael Broman, Alan K Davis, Stacey Armstrong, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 12, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of ResearchDavid B Yaden, Marianna Graziosi, Alexa M Owen, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Digital Health|June 16, 2023
Effectiveness of biofeedback-assisted asynchronous telerehabilitation in musculoskeletal care: A systematic reviewDora Janela, Fabíola Costa, Brandon Weiss, et al.
Psychological Medicine|June 2, 2023
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionBrandon Weiss, Induni Ginige, Lu Shannon, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
Neuroscience and Biobehavioral Reviews|February 4, 2024
Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personalityIvana Solaja, Kate Haldane, Natasha Mason, et al.
Sleep|February 6, 2014
Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trialLisa S Talbot, Shira Maguen, Thomas J Metzler, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Ayahuasca: A review of historical, pharmacological, and therapeutic aspectsSimon G D Ruffell, Max Crosland-Wood, Rob Palmer, et al.
Nature Medicine|February 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trialDavid Erritzoe, Tommaso Barba, Tiffanie Benway, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approachClaudio Agnorelli, Joseph Peill, Gabriela Sawicka, et al.
Harm Reduction Journal|December 31, 2025
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysisMichael Broman, Alan K Davis, Stacey Armstrong, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 12, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of ResearchDavid B Yaden, Marianna Graziosi, Alexa M Owen, et al.
Pageof 4